BMO Capital Maintains Precision BioSciences(DTIL.US) With Hold Rating, Maintains Target Price $34

Futu News12:32 · Ratings

Precision BioSciences (DTIL) Reports Q3 Loss, Misses Revenue Estimates

Zacks Nov 4 20:25

Precision BioSciences | 10-Q: Q3 2024 Earnings Report

SECNov 4 20:19 · Announcements

Express News | Precision BioSciences Shares Down 3.6% Premarket After Q3 Results

BreakingsNov 4 20:17

Precision BioSciences GAAP EPS of -$2.25, Revenue of $0.6M

Seeking AlphaNov 4 20:11

Earnings Flash (DTIL) PRECISION BIOSCIENCES Reports Q3 Revenue $576,000

MT NewswiresNov 4 20:05